Safety profile of nivolumab (NIVO) and ipilimumab (IPI) combination therapy in patients (pts) with advanced melanoma (MEL) Abstract uri icon

authors

  • Sznol, M
  • Ferrucci, PF
  • Hogg, D
  • Atkins, M
  • Wolter, P
  • Guidoboni, M
  • Lebbe, C
  • Kirkwood, J
  • Schachter, J
  • Daniels, G
  • Hassel, J
  • Cebon, J
  • Gerritsen, W
  • Atkinson, V
  • Thomas, L
  • McCaffrey, J
  • Power, D
  • Jiang, J
  • Hodi, FS
  • Wolchok, J

publication date

  • October 2016